Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
29.58
-0.30 (-1.00%)
At close: May 9, 2025, 2:57 PM CST
Zhejiang Haisen Pharmaceutical Company Description
Zhejiang Haisen Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical active pharmaceutical ingredient and intermediates in China.
The company offers APIs for anti-gastric ulcer, antilipemic agent, antipyretic analgesics, antidepressant, analgesic, antibacterial agent, antipyretic analgesics, histamines drug, and anticonvulsant.
It also provides chemical product for intermediates and food additives. Zhejiang Haisen Pharmaceutical Co., Ltd. was founded in 1998 and is based in Dongyang, China.
Zhejiang Haisen Pharmaceutical Co., Ltd.
Country | China |
Founded | 1998 |
Industry | Drug Manufacturers - General |
Sector | Healthcare |
Employees | 663 |
CEO | Lin Ai |
Contact Details
Address: Liushi Street Dongyang, 322104 China | |
Phone | 86 579 8676 8756 |
Website | haisenpharma.com |
Stock Details
Ticker Symbol | 001367 |
Exchange | Shenzhen Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Lin Ai | GM and Director |
Aijuan Pan | Chief Financial Officer |
Kangkang Hu | Company Secretary |